Discover how Herpafend’s natural formula helps support immune strength, reduce cold sore outbreaks, and promote lasting ...

Q3 revenues from the U.S. market Robust balance sheet with $16.4 M in cash and cash equivalents, no debt, low burn rate provides ample runway to cash flow positive In Process of Transitioning ...

Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...